Found: 90
Select item for more details and to access through your institution.
The highly malignant phenotype of anaplastic thyroid carcinoma cell lines is recessive.
- Published in:
- European Journal of Endocrinology, 2000, v. 143, n. 4, p. 515, doi. 10.1530/eje.0.1430515
- By:
- Publication type:
- Article
Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 4, p. 1030, doi. 10.1210/clinem/dgab851
- By:
- Publication type:
- Article
Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 11, p. 4935, doi. 10.1172/JCI69766
- By:
- Publication type:
- Article
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Switch in signaling control of mTORC1 activity after oncoprotein expression in thyroid cancer cell lines.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancers along the spectrum of disease progression.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.
- Published in:
- 2013
- By:
- Publication type:
- journal article
[<sup>18</sup>F]TFB PET/CT misses intense [<sup>124</sup>I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054302
- By:
- Publication type:
- Article
Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid Nodules.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 6, p. 2092, doi. 10.1210/jc.2009-0247
- By:
- Publication type:
- Article
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.
- Published in:
- 2008
- By:
- Publication type:
- journal article
BRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Analysis of BRAF Point Mutation and RET/PTC Rearrangement Refines the Fine-Needle Aspiration Diagnosis of Papillary Thyroid Carcinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 10, p. 5175, doi. 10.1210/jc.2003-032221
- By:
- Publication type:
- Article
Editorial: Challenging Dogma in Thyroid Cancer Molecular Genetics—Role of RET/PTC and BRAF in Tumor Initiation.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 9, p. 4264, doi. 10.1210/jc.2004-1426
- By:
- Publication type:
- Article
BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 11, p. 5399, doi. 10.1210/jc.2003-030838
- By:
- Publication type:
- Article
Isozyme-specific abnormalities of PKC in thyroid cancer: evidence for post-transcriptional changes in PKC epsilon.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Studies of Allelic Loss in Thyroid Tumors Reveal Major Differences in Chromosomal Instability between Papillary and Follicular Carcinomas.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1998, v. 83, n. 2, p. 525, doi. 10.1210/jc.83.2.525
- By:
- Publication type:
- Article
Editorial: Familial Nonmedullary Thyroid Carcinoma— The Case for Genetic Susceptibility.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1997, v. 82, n. 2, p. 343, doi. 10.1210/jcem.82.2.3787
- By:
- Publication type:
- Article
Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1996, v. 81, n. 11, p. 3898, doi. 10.1210/jcem.81.11.8923835
- By:
- Publication type:
- Article
Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1996, v. 81, n. 1, p. 9, doi. 10.1210/jcem.81.1.8550800
- By:
- Publication type:
- Article
Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01676-9
- By:
- Publication type:
- Article
Can Risk-Adapted Treatment Recommendations Replace the 'One Size Fits All' Approach for Early-Stage Thyroid Cancer Patients?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 7, p. 592
- By:
- Publication type:
- Article
Dynamic contrast‐enhanced MRI model selection for predicting tumor aggressiveness in papillary thyroid cancers.
- Published in:
- NMR in Biomedicine, 2020, v. 33, n. 1, p. N.PAG, doi. 10.1002/nbm.4166
- By:
- Publication type:
- Article
Acute expression of RET/PTC induces isozyme-specific activation and subsequent downregulation of PKC? in PCCL3 thyroid cells.
- Published in:
- Oncogene, 2003, v. 22, n. 44, p. 6830, doi. 10.1038/sj.onc.1206829
- By:
- Publication type:
- Article
RET/PTC-induced dedifferentiation of thyroid cells is mediated through Y1062 signaling through SHC-RAS-MAP kinase.
- Published in:
- Oncogene, 2003, v. 22, n. 28, p. 4406, doi. 10.1038/sj.onc.1206602
- By:
- Publication type:
- Article
Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes.
- Published in:
- Oncogene, 2003, v. 22, n. 2, p. 246, doi. 10.1038/sj.onc.1206112
- By:
- Publication type:
- Article
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
- Published in:
- Thyroid, 2024, v. 34, n. 2, p. 167, doi. 10.1089/thy.2023.0279
- By:
- Publication type:
- Article
RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance.
- Published in:
- Thyroid, 2024, v. 34, n. 4, p. 450, doi. 10.1089/thy.2023.0544
- By:
- Publication type:
- Article
Progress in Thyroid Cancer Genomics: A 40-Year Journey.
- Published in:
- Thyroid, 2023, v. 33, n. 11, p. 1271, doi. 10.1089/thy.2023.0045
- By:
- Publication type:
- Article
Active Surveillance of Papillary Thyroid Cancer: Frequency and Time Course of the Six Most Common Tumor Volume Kinetic Patterns.
- Published in:
- Thyroid, 2022, v. 32, n. 11, p. 1337, doi. 10.1089/thy.2022.0325
- By:
- Publication type:
- Article
A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid Cancer.
- Published in:
- Thyroid, 2022, v. 32, n. 7, p. 799, doi. 10.1089/thy.2022.0050
- By:
- Publication type:
- Article
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.
- Published in:
- Thyroid, 2022, v. 32, n. 3, p. 273, doi. 10.1089/thy.2021.0565
- By:
- Publication type:
- Article
Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.
- Published in:
- Thyroid, 2020, v. 30, n. 10, p. 1505, doi. 10.1089/thy.2020.0086
- By:
- Publication type:
- Article
Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.
- Published in:
- Thyroid, 2019, v. 29, n. 1, p. 79, doi. 10.1089/thy.2018.0424
- By:
- Publication type:
- Article
Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease.
- Published in:
- Thyroid, 2018, v. 28, n. 9, p. 1180, doi. 10.1089/thy.2018.0214
- By:
- Publication type:
- Article
BRAF V600E Expression in Thyrocytes Causes Recruitment of Immunosuppressive STABILIN-1 Macrophages.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4687, doi. 10.3390/cancers14194687
- By:
- Publication type:
- Article
Defining the Genomic Landscape of Diffuse Sclerosing Papillary Thyroid Carcinoma: Prognostic Implications of RET Fusions.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 9, p. 5525, doi. 10.1245/s10434-024-15500-9
- By:
- Publication type:
- Article
Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15<sup>INK4b</sup> and p16<sup>INK4a</sup> in human thyroid carcinoma cell lines and primary thyroid carcinomas.
- Published in:
- Cancer (0008543X), 1998, v. 83, n. 10, p. 2185, doi. 10.1002/(SICI)1097-0142(19981115)83:10<2185::AID-CNCR18>3.0.CO;2-4
- By:
- Publication type:
- Article
Characteristics of follicular tumors and nonneoplastic thyroid lesions in children and adolescents exposed to radiation as a result of the Chernobyl disaster.
- Published in:
- 1995
- By:
- Publication type:
- journal article
The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway.
- Published in:
- Oncogene, 2000, v. 19, n. 34, p. 3948, doi. 10.1038/sj.onc.1203723
- By:
- Publication type:
- Article
Prevalence of minisatellite and microsatellite instability in radiation-induced post-Chernobyl pediatric thyroid carcinomas.
- Published in:
- Oncogene, 1998, v. 17, n. 15, p. 1983, doi. 10.1038/sj.onc.1202120
- By:
- Publication type:
- Article
Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets.
- Published in:
- Nucleic Acids Research, 1997, v. 25, n. 19, p. 3823, doi. 10.1093/nar/25.19.3823
- By:
- Publication type:
- Article
Oncogene-induced DNA damage: cyclic AMP steps into the ring.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Papillary thyroid carcinoma tall cell subtype (PTC‐TC) and high‐grade differentiated thyroid carcinoma tall cell phenotype (HGDTC‐TC) have different clinical behaviour: a retrospective study of 1456 patients.
- Published in:
- Histopathology, 2024, v. 84, n. 7, p. 1130, doi. 10.1111/his.15157
- By:
- Publication type:
- Article